Amplicon, Inc., Cold Spring Harbor, NY, is a biotechnology company specializing in the identification of cancer genes. Northwood invested in several rounds of equity financing, beginning in 1995. Amplicon was acquired in 1997 by Tularik, Inc. for stock. Tularik completed its initial public offering in December 1999, raising $97 million. Tularik was subsequently acquired by Amgen.